Literature DB >> 22835948

Donor age and ABCB1 1199G>A genetic polymorphism are independent factors affecting long-term renal function after kidney transplantation.

Martine De Meyer1, Vincent Haufroid, Laure Elens, Fabio Fusaro, Damiano Patrono, Luc De Pauw, Nada Kanaan, Eric Goffin, Michel Mourad.   

Abstract

BACKGROUND: In renal tubular cells, cytochrome P4503A enzyme and adenosine triphosphate-binding cassette transporter activities result in intracellular drug or metabolite exposure variability, depending on genetic polymorphisms. Our aim was to establish whether long-term renal function is affected by genetic polymorphisms in biotransformation enzymes and drug transporters of the donor after kidney transplantation.
MATERIALS AND METHODS: The study was conducted in a selected cohort of 97 kidney recipients. Genotyping of donors was performed on renal biopsy samples obtained before transplantation. Serum creatinine levels and Cockcroft-Gault estimated glomerular filtration rate were considered 1 y after transplantation and at the last follow-up.
RESULTS: Long-term function was significantly better in recipients of an organ from donors carrying the ABCB1 1199A mutated allele (median and range creatinine values were 1.1 mg/dL [0.8-1.5mg/dL] in case of at least one ABCB1 1199A allele versus 1.5 mg/dL [0.7-3.7 mg/dL] for homozygous carriers of wild-type allele, P < 0.01). ABCB1 1199G>A polymorphism and donor age had an independent impact on both serum creatinine and estimated glomerular filtration rate. Unlike donor age, the mutated ABCB1 1199A allele was found to have a protective effect on renal function.
CONCLUSIONS: Donor age and ABCB1 1199G>A polymorphism affect long-term renal function after transplantation. Analysis of genetic factors offers a promising approach to calcineurin inhibitor toxicity risk assessment.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22835948     DOI: 10.1016/j.jss.2012.06.070

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

Review 1.  Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks.

Authors:  Laure Elens; Rachida Bouamar; Nauras Shuker; Dennis A Hesselink; Teun van Gelder; Ron H N van Schaik
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 2.  Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.

Authors:  Teun van Gelder; Ron H van Schaik; Dennis A Hesselink
Journal:  Nat Rev Nephrol       Date:  2014-09-23       Impact factor: 28.314

3.  The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients.

Authors:  Beatriz Tavira; Juan Gómez; Carmen Díaz-Corte; Diego Coronel; Carlos Lopez-Larrea; Beatriz Suarez; Eliecer Coto
Journal:  J Hum Genet       Date:  2015-02-12       Impact factor: 3.172

Review 4.  Pharmacogenetics in kidney transplantation: recent updates and potential clinical applications.

Authors:  Laure Elens; Dennis A Hesselink; Ron H N van Schaik; Teun van Gelder
Journal:  Mol Diagn Ther       Date:  2012-12       Impact factor: 4.074

5.  Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.

Authors:  Jun Ma; Jasmin Divers; Nicholette D Palmer; Bruce A Julian; Ajay K Israni; David Schladt; Stephen O Pastan; Kryt Chattrabhuti; Michael D Gautreaux; Vera Hauptfeld; Robert A Bray; Allan D Kirk; W Mark Brown; Robert S Gaston; Jeffrey Rogers; Alan C Farney; Giuseppe Orlando; Robert J Stratta; Meijian Guan; Amudha Palanisamy; Amber M Reeves-Daniel; Donald W Bowden; Carl D Langefeld; Pamela J Hicks; Lijun Ma; Barry I Freedman
Journal:  Kidney Int       Date:  2015-04-08       Impact factor: 10.612

Review 6.  Personalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicine.

Authors:  Gianluigi Zaza; Simona Granata; Paola Tomei; Alessandra Dalla Gassa; Antonio Lupo
Journal:  Int J Mol Sci       Date:  2015-02-17       Impact factor: 5.923

7.  Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia.

Authors:  J Gregers; H Gréen; I J Christensen; K Dalhoff; H Schroeder; N Carlsen; S Rosthoej; B Lausen; K Schmiegelow; C Peterson
Journal:  Pharmacogenomics J       Date:  2015-01-13       Impact factor: 3.550

Review 8.  Donor-Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms.

Authors:  Priyanka Jethwani; Arundati Rao; Laurine Bow; Madhav C Menon
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.